Reports for HIKMA CANADA LIMITED

Company Name

HIKMA CANADA LIMITED

Totals

Shortage reports

104
Actual shortage: 20 (19%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (1%)
Resolved: 83 (80%)

Discontinuation Reports

9
To be discontinued: 3 (33%)
Discontinued: 6 (67%)
Reversed: 0 (0%)

Late reports

16 (14%)

Overdue reports

17 (74%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TESTOSTERONE ENANTHATE INJECTION, USP 200MG SOLUTION Resolved 2024-09-26 2024-12-13 238542
TESTOSTERONE ENANTHATE INJECTION, USP 200MG SOLUTION Resolved 2025-02-04 2025-03-25 249532
TESTOSTERONE ENANTHATE INJECTION, USP 200MG SOLUTION Actual shortage 2025-04-25 2025-04-26 255771
THIOTEPA FOR INJECTION, BP 15MG POWDER FOR SOLUTION Resolved 2024-09-26 2024-11-22 238545

Showing 101 to 104 of 104

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.2% SOLUTION Discontinued 2025-03-24 2025-04-07 253339
BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.2% SOLUTION Discontinued 2025-03-24 2025-04-02 253342
DORZOLAMIDE AND TIMOLOL EYE DROPS BP 5MG 20MG SOLUTION Discontinued 2024-11-01 2024-11-01 241852
LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION 5MG 50MCG SOLUTION Discontinued 2024-10-01 2024-10-02 239073
LATANOPROST OPHTHALMIC SOLUTION 50MCG SOLUTION Discontinued 2025-03-24 2025-04-02 253336
LIDOCAINE HYDROCHLORIDE INJECTION USP 10MG SOLUTION Discontinued 2024-04-19 2024-04-22 225805
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 2G 0.25G POWDER FOR SOLUTION To be discontinued 2022-07-21 2022-07-21 165188
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 0.375G 3G POWDER FOR SOLUTION To be discontinued 2022-07-21 2022-07-21 165193
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 0.5G 4G POWDER FOR SOLUTION To be discontinued 2022-07-21 2022-07-21 165196

Showing 1 to 9 of 9